Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint Study.

Massimo E. Abate, Silvia Cammelli, Letizia Ronchi, Barbara Diletto, Lorenza Gandola, Anna Paioli, Alessandra Longhi, Emanuela Palmerini, Nadia Puma, Angela Tamburini, Maurizio Mascarin, Elisa Coassin, Arcangelo Prete, Sebastian D. Asaftei, Carla Manzitti, Gianni Bisogno, Marta Pierobon, Luca Coccoli, Mariella Capasso, Giovanni GrignaniGiuseppe M. Milano, Valentina Kiren, Franca Fagioli, Stefano Ferrari, Piero Picci, Elisa Carretta, Roberto Luksch

Research output: Contribution to journalArticlepeer-review

Abstract

To analyze toxicity and outcome predictors in Ewing sarcoma patients with lung metastases treated with busulfan and melphalan (BU-MEL) followed by whole-lung irradiation (WLI). This retrospective study included 68 lung metastatic Ewing Sarcoma patients who underwent WLI after BU-MEL with autologous stem cell transplantation, as part of two prospective and consecutive treatment protocols. WLI 12 Gy for
Original languageUndefined/Unknown
JournalCancers
Volume13
DOIs
Publication statusPublished - Jun 1 2021

Keywords

  • Ewing sarcoma
  • busulfan
  • lung irradiation
  • melphalan
  • oncology
  • pulmonary metastasis

Cite this